High doses of docosahexaenoic acid (DHA) supplements may help prevent progression to dementia in people who carry the apolipoprotein ε4 allele (APOE4), a new review suggests.
The hope is that this new review of current evidence will spark renewed interest in funding research into DHA in APOE4 carriers, said lead author Hussein N. Yassine, MD, assistant professor, endocrinology, Department of Medicine, Keck School of Medicine University of Southern California, Los Angeles.
“What we are trying to say is that maybe we should invest more in studies looking at DHA in the right population,” said Dr Yassine.
Advertisements
